Identification of Four Amoebicidal Nontoxic Compounds by a Molecular Docking Screen of Naegleria fowleri Sterol Δ8-Δ7-Isomerase and Phenotypic Assays.
Da ShiKirti Kandhwal ChahalPatricia OtoLouis-Felix NothiasAnjan DebnathJames H McKerrowLarissa M PodustRuben AbagyanPublished in: ACS infectious diseases (2019)
Naegleria fowleri is a free-living amoeba causing primary amoebic meningoencephalitis, a rapid-onset brain infection in humans with over 97% mortality rate. Despite some progress in the treatment of the disease, there is no single, proven, evidence-based treatment with a high probability of cure. Here we report the chemical library screening and experimental identification of four new compounds with amoebicidal effects against N. fowleri. The chemical library was screened by molecular docking against a homology model of sterol Δ8-Δ7 isomerase (NfERG2). Thirty top-ranking hits were then tested in a cell-based assay for antiproliferative/amoebicidal activities. Eight chemicals exhibited nearly 100% inhibition of N. fowleri at 50 μM, with the EC50 values ranging from 6 to 25 μM. A cell toxicity assay using human HEK-293 cells was also performed. Four of the compounds preferentially kill amoeba cells with no apparent human cell toxicities. These compounds fall into two distinct chemical scaffolds with druglike properties.
Keyphrases
- molecular docking
- single cell
- high throughput
- induced apoptosis
- endothelial cells
- molecular dynamics simulations
- cell therapy
- cell cycle arrest
- oxidative stress
- induced pluripotent stem cells
- computed tomography
- multiple sclerosis
- magnetic resonance
- pluripotent stem cells
- replacement therapy
- resting state
- cerebral ischemia
- bioinformatics analysis
- brain injury